Location
United States, North America
Cheque size
$250K - $5M
Investment Stage
Pre Seed
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
EnergyTech
Health and Wellbeing
HealthTech
Medical Devices
Material Science
About Investor
Widya Mulyasasmita, Ph.D., is Co-Founder and Managing Partner at BEVC, focusing on early-stage investments in biotechnology, life sciences, healthcare, and emerging technologies. She previously held investment roles at B Capital and Red Tree VC and has a Ph.D. in Bioengineering from Stanford University.
Previous investments
Triumvira Immunologics
45M |2022
OncoMyx Therapeutics
50M |2021
Viron
50M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.
